See more : Canopus BioPharma Incorporated (CBIA) Income Statement Analysis – Financial Results
Complete financial analysis of British American Tobacco p.l.c. (BTI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of British American Tobacco p.l.c., a leading company in the Tobacco industry within the Consumer Defensive sector.
You may be interested
- VGI Partners Global Investments Limited (VG1.AX) Income Statement Analysis – Financial Results
- Weltrend Semiconductor, Inc. (2436.TW) Income Statement Analysis – Financial Results
- The Mint Corporation (MITJF) Income Statement Analysis – Financial Results
- Romande Energie Holding SA (HREN.SW) Income Statement Analysis – Financial Results
- Rafael Holdings, Inc. (RFL) Income Statement Analysis – Financial Results
British American Tobacco p.l.c. (BTI)
About British American Tobacco p.l.c.
British American Tobacco p.l.c. provides tobacco and nicotine products to consumers worldwide. It offers vapour, tobacco heating, and modern oral nicotine products; combustible products; and traditional oral products, such as snus and moist snuff. The company offers its products under the Kent, Dunhill, Lucky Strike, Pall Mall, Rothmans, Camel, Newport, Natural American Spirit, being Vapour, THP, and Modern Oral brands. It distributes its products to retail outlets. British American Tobacco p.l.c. was incorporated in 1902 and is headquartered in London, the United Kingdom.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 27.28B | 27.66B | 25.68B | 25.78B | 25.88B | 24.49B | 20.29B | 14.75B | 13.10B | 13.97B | 15.26B | 15.19B | 15.40B | 14.88B | 14.21B | 12.12B | 10.02B | 9.76B | 9.33B | 10.77B | 25.62B | 24.68M | 11.37B | 10.92B | 9.07B | 7.12B | 7.15B | 7.24B | 6.77B |
| Cost of Revenue | 4.64B | 4.55B | 4.38B | 4.14B | 4.44B | 4.55B | 5.03B | 3.73B | 3.03B | 3.03B | 3.24B | 3.31B | 3.43B | 3.71B | 3.95B | 3.32B | 2.77B | 2.87B | 2.76B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 22.64B | 23.10B | 21.30B | 21.64B | 21.44B | 19.94B | 15.26B | 11.02B | 10.07B | 10.94B | 12.02B | 11.88B | 11.97B | 11.18B | 10.26B | 8.81B | 7.25B | 6.89B | 6.57B | 10.77B | 25.62B | 24.68M | 11.37B | 10.92B | 9.07B | 7.12B | 7.15B | 7.24B | 6.77B |
| Gross Profit Ratio | 82.99% | 83.53% | 82.94% | 83.95% | 82.85% | 81.42% | 75.20% | 74.69% | 76.85% | 78.31% | 78.75% | 78.20% | 77.75% | 75.09% | 72.21% | 72.64% | 72.33% | 70.58% | 70.40% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 181.00M | 138.00M | 141.00M | 121.00M | 126.00M | 105.00M | 80.00M | 53.00M | 60.00M | 74.00M | 91.00M | 93.00M | 81.00M | 82.00M | 51.00M | 50.00M | 43.00M | 36.00M | 29.00M | 29.00M | 73.00M | 62.00M | 59.00M | 59.00M | 58.00M | 45.00M | 42.00M | 37.00M | 43.00M |
| General & Administrative | 29.00M | 29.00M | 27.10M | 28.30M | 25.30M | 25.40M | 47.70M | 11.40M | 12.60M | 14.90M | 14.80M | 15.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 1.15B | 1.16B | 1.24B | 1.10B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.18B | 1.19B | 1.27B | 28.30M | 25.30M | 25.40M | 47.70M | 11.40M | 12.60M | 14.90M | 14.80M | 15.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 37.03B | 6.50B | 9.65B | 11.52B | 12.27B | -6.58B | -5.20B | -3.48B | -3.05B | -3.68B | -3.63B | -3.61B | -1.31B | -1.23B | -1.08B | -954.00M | -898.00M | -888.00M | -784.00M | -252.00M | 292.00M | -50.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 38.39B | 7.82B | 11.07B | 11.67B | 12.42B | 10.63B | 8.78B | 6.36B | 5.51B | 6.40B | 6.49B | 6.47B | 10.42B | 10.20B | 10.01B | 5.38B | 4.42B | 4.26B | 4.22B | 8.39B | 22.92B | 22.12M | 8.76B | 8.36B | 7.16B | 5.53B | 5.31B | 5.62B | 5.13B |
| Cost & Expenses | 43.03B | 12.38B | 15.45B | 15.81B | 16.86B | 15.18B | 13.82B | 10.10B | 8.55B | 9.43B | 9.73B | 9.78B | 13.85B | 13.90B | 13.96B | 8.69B | 7.19B | 7.13B | 6.98B | 8.39B | 22.92B | 22.12M | 8.76B | 8.36B | 7.16B | 5.53B | 5.31B | 5.62B | 5.13B |
| Interest Income | 167.00M | 92.00M | 35.00M | 50.00M | 210.00M | 103.00M | 103.00M | 44.00M | 646.00M | 67.00M | 66.00M | 49.00M | 82.00M | 60.00M | 85.00M | 131.00M | 111.00M | 122.00M | 106.00M | 112.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.89B | 1.66B | 1.52B | 1.80B | 1.81B | 1.48B | 1.20B | 681.00M | 584.00M | 484.00M | 532.00M | 505.00M | 567.00M | 583.00M | 602.00M | 535.00M | 382.00M | 410.00M | 373.00M | 368.00M | 209.00M | 184.00K | 409.00M | 489.00M | 370.00M | 355.00M | 368.00M | 340.00M | 306.00M |
| Depreciation & Amortization | 24.00B | 1.06B | 949.00M | 834.00M | 931.00M | 990.00M | 817.00M | 543.00M | 428.00M | 523.00M | 477.00M | 475.00M | 817.00M | 897.00M | 611.00M | 430.00M | 336.00M | 353.00M | 383.00M | 375.00M | 882.00M | 338.00M | 396.00M | 401.00M | 350.00M | 297.00M | 239.00M | 231.00M | 221.00M |
| EBITDA | 8.83B | 12.29B | 11.67B | 11.70B | 11.02B | 11.02B | 31.55B | 7.52B | 6.86B | 5.46B | 6.89B | 6.65B | 6.32B | 5.48B | 5.19B | 4.64B | 3.80B | 3.53B | 3.34B | 4.38B | 2.38B | 2.78B | 2.87B | 2.41B | 2.09B | 1.39B | 1.48B | 2.20B | 1.99B |
| EBITDA Ratio | 32.35% | 45.97% | 45.80% | 46.24% | 43.43% | 44.41% | 156.17% | 51.07% | 52.40% | 41.91% | 44.61% | 43.63% | 42.66% | 43.73% | 38.38% | 41.47% | 38.63% | 34.50% | 37.37% | 27.82% | 12.70% | 10.84% | 29.08% | 29.20% | 27.87% | 27.68% | 28.30% | 29.13% | 29.26% |
| Operating Income | -15.75B | 10.52B | 10.23B | 9.96B | 9.02B | 9.31B | 6.48B | 4.66B | 4.56B | 4.55B | 5.53B | 5.41B | 4.72B | 4.32B | 4.10B | 3.57B | 2.90B | 2.62B | 2.42B | 3.76B | 1.85B | 2.18M | 2.18B | 1.78B | 1.48B | 1.01B | 1.30B | 1.71B | 1.65B |
| Operating Income Ratio | -57.73% | 38.05% | 39.85% | 38.65% | 34.84% | 38.02% | 31.91% | 31.56% | 34.78% | 32.54% | 36.21% | 35.63% | 30.66% | 29.01% | 28.86% | 29.47% | 28.99% | 26.86% | 25.95% | 34.92% | 7.23% | 8.83% | 19.14% | 16.34% | 16.30% | 14.20% | 18.22% | 23.67% | 24.31% |
| Total Other Income/Expenses | -1.31B | -1.20B | -1.07B | -1.29B | -1.10B | -962.00M | 23.12B | 1.59B | 1.30B | 302.00M | 273.00M | 220.00M | 210.00M | 70.00M | -21.00M | 112.00M | 173.00M | 142.00M | 164.00M | -130.00M | -210.00M | -67.00M | -111.00M | -262.00M | -108.00M | -273.00M | -428.00M | -88.00M | -186.00M |
| Income Before Tax | -17.06B | 9.32B | 9.16B | 8.67B | 7.91B | 8.35B | 29.59B | 6.25B | 5.86B | 4.85B | 5.80B | 5.65B | 4.93B | 4.39B | 4.08B | 3.68B | 3.08B | 2.76B | 2.58B | 3.63B | 1.57B | 2.11M | 2.07B | 1.52B | 1.37B | 738.00M | 875.00M | 1.63B | 1.46B |
| Income Before Tax Ratio | -62.53% | 33.72% | 35.68% | 33.64% | 30.58% | 34.10% | 145.83% | 42.34% | 44.68% | 34.70% | 38.00% | 37.18% | 32.02% | 29.48% | 28.72% | 30.39% | 30.71% | 28.31% | 27.71% | 33.71% | 6.12% | 8.56% | 18.16% | 13.94% | 15.11% | 10.37% | 12.23% | 22.46% | 21.56% |
| Income Tax Expense | -2.87B | 2.48B | 2.19B | 2.11B | 2.06B | 2.14B | -8.11B | 1.41B | 1.33B | 1.46B | 1.60B | 1.53B | 1.56B | 1.25B | 1.12B | 1.03B | 790.00M | 716.00M | 690.00M | 673.00M | 779.00M | 818.00K | 886.00M | 660.00M | 673.00M | 277.00M | 357.00M | 520.00M | 490.00M |
| Net Income | -14.37B | 6.67B | 6.80B | 6.40B | 5.70B | 6.03B | 37.53B | 4.65B | 4.29B | 3.12B | 3.90B | 3.84B | 3.10B | 2.88B | 2.71B | 2.46B | 2.13B | 1.90B | 1.77B | 2.83B | 631.00M | 1.15M | 1.01B | 692.00M | 556.00M | 346.00M | 412.00M | 988.00M | 860.00M |
| Net Income Ratio | -52.66% | 24.10% | 26.48% | 24.83% | 22.04% | 24.63% | 184.96% | 31.51% | 32.74% | 22.30% | 25.58% | 25.29% | 20.10% | 19.34% | 19.09% | 20.27% | 21.26% | 19.42% | 18.95% | 26.25% | 2.46% | 4.67% | 8.88% | 6.34% | 6.13% | 4.86% | 5.76% | 13.64% | 12.70% |
| EPS | -6.49 | 2.93 | 2.97 | 2.80 | 2.50 | 2.64 | 18.36 | 2.50 | 2.31 | 1.67 | 2.05 | 1.98 | 1.57 | 1.45 | 1.37 | 1.23 | 1.05 | 0.92 | 0.84 | 1.13 | 0.27 | 0.51 | 0.44 | 0.30 | 0.25 | 0.22 | 0.27 | 0.64 | 0.56 |
| EPS Diluted | -6.47 | 2.92 | 2.96 | 2.79 | 2.49 | 2.63 | 18.30 | 2.49 | 2.30 | 1.67 | 2.05 | 1.97 | 1.56 | 1.44 | 1.36 | 1.23 | 1.04 | 0.91 | 0.84 | 1.13 | 0.27 | 0.50 | 0.44 | 0.30 | 0.25 | 0.22 | 0.26 | 0.64 | 0.56 |
| Weighted Avg Shares Out | 2.22B | 2.26B | 2.29B | 2.29B | 2.28B | 2.29B | 2.04B | 1.86B | 1.86B | 1.86B | 1.90B | 1.94B | 1.97B | 1.98B | 1.98B | 1.99B | 2.03B | 2.06B | 2.10B | 2.09B | 2.08B | 2.15B | 2.15B | 2.15B | 1.91B | 1.56B | 1.55B | 1.55B | 1.55B |
| Weighted Avg Shares Out (Dil) | 2.23B | 2.27B | 2.30B | 2.30B | 2.29B | 2.29B | 2.05B | 1.87B | 1.86B | 1.87B | 1.91B | 1.95B | 1.98B | 1.99B | 1.99B | 2.01B | 2.04B | 2.08B | 2.11B | 2.13B | 2.36B | 2.21B | 2.30B | 2.34B | 2.06B | 1.57B | 1.57B | 1.55B | 1.55B |
BAT non-tobacco progress a wild card in next week's update
British American Tobacco PLC (LSE:BATS), in line with its peer Imperial Brands, has been in favour in recent months as investors have focused on cash flow rather than declining volumes of cigarette sales. Volumes are tipped to drop 5.9% on...
Top 10 High-Yield Picks For December 2024 With Strategic Allocations: 5 Yield Over 7%
In this article, I will share with you 10 attractive high dividend yield companies that could help you enhance your portfolio's ability to generate dividend income. I will also share allocation limits for each of the selected companies to help...
British American Tobacco: New Glo Hilo Looks Like A Winner
The recently introduced Glo Hilo shows BTI is listening to consumer feedback. The company is getting more innovative and is starting to launch great products that could lead to growth. BTI launched Glo Hilo in Serbia as a test market,...
Is British American Tobacco a Buy, Sell, or Hold in 2025?
If you're a dividend investor, you've likely considered buying British American Tobacco (BTI), if you don't own it already.
6 High-Yield Dividend Aristocrats To Buy With The Market At Record Highs
The market is back to record highs, and many investors are worried about putting new money to work. Combining maximum yield with maximum total return optimizes current yield and future retirement income without sacrificing medium- to long-term returns. These six...
5 Blue Chips Yielding Over 7% I'm Considering Buying, And So Should You
I'm seeking 6%-plus yielding blue-chip bargains for my family's portfolio, with a focus on long-term income growth and minimal volatility. My ZEUS Family portfolio strategy involves annual rebalancing and screening for undervalued, high-quality stocks with strong fundamentals and risk management....
Best Stock to Buy Right Now: Altria vs. British American Tobacco
Altria (MO 0.10%) has a huge 7.1% dividend yield. British American Tobacco (BTI 0.61%) has an even higher yield of roughly 8%.
These Two ~8% Yielders Are Massive Bargains Now
Yields have started to come down within most yield-driven segments. The risk is that we fall back into a yield-starvation era. In my view, income-oriented investors have to be bold and lock in high yields now, while they are still...
Where Will Ultra-High Yield British American Tobacco Be in 5 Years?
Where Will Ultra-High Yield British American Tobacco Be in 5 Years?
Want Decades of Passive Income? 3 Stocks to Buy Right Now.
Want Decades of Passive Income? 3 Stocks to Buy Right Now.
Source: https://incomestatements.info
Category: Stock Reports